DurgicalDurgical
EN
Open the app

Type 2 diabetes mellitus !

Type 2 diabetes is a long-term disease in which the body resists insulin and the pancreas slowly fails, so blood sugar stays high. It is the main adult form.

Updated 2026-10-30

Structures involved

Tap one to see what it is and open it in 3D.

In biochemistry

In histology

In embryology

In the clinical exam

In physiology

Why it happens

What it is

A chronic metabolic disease in which insulin resistance and a progressive failure of the pancreatic beta cells lead to persistently high blood glucose. It is the most common form of diabetes in adults.

Who gets it

Common worldwide and in Latin America, rising with urbanisation, obesity and ageing. In Peru's CRONICAS cohort (four settings), baseline prevalence was 7.1% and incidence 1.95 per 100 person-years, higher at high altitude; obesity was the main attributable risk. Many people are unaware they have it until a complication appears.

Causes

  • Insulin resistance in muscle, liver and fat tissue
  • Progressive loss of beta-cell function in the pancreatic islets
  • Strong genetic and family component, interacting with lifestyle

Risk factors

  • Overweight and central (abdominal) obesity
  • Physical inactivity and a diet rich in refined carbohydrates and ultra-processed food
  • First-degree relative with diabetes
  • Older age, although it is increasingly seen in young adults and adolescents
  • Prediabetes or previous gestational diabetes
  • Hypertension, dyslipidaemia and polycystic ovary syndrome

Pathophysiology

Tissues respond poorly to insulin, so the pancreas first secretes more to compensate. Over years beta cells fail, the liver keeps releasing glucose and muscle takes up less, and fasting and after-meal glucose rise. Chronic hyperglycaemia damages small vessels (retina, kidney, nerves) and speeds atherosclerosis in large arteries.

Classification

  • Prediabetes: impaired fasting glucose or impaired glucose tolerance
  • Type 2 diabetes without complications
  • Type 2 diabetes with microvascular complications (retinopathy, nephropathy, neuropathy)
  • Type 2 diabetes with macrovascular complications (coronary, cerebrovascular, peripheral artery disease)

Symptoms and signs

  • Often no symptoms for years; found on screening
  • Excessive thirst (polydipsia) and frequent urination (polyuria)
  • Fatigue and blurred vision
  • Recurrent infections, such as genital candidiasis or skin infections, and slow wound healing
  • Numbness, burning or tingling in the feet
  • Acanthosis nigricans (dark velvety skin on the neck or armpits) as a sign of insulin resistance

Diagnosis

Clinical
History of symptoms and risk factors, weight and waist, blood pressure, and a full foot examination (pulses, monofilament sensation, skin). Many cases are found by screening people at risk.
Tests
Fasting plasma glucose, HbA1c and the oral glucose tolerance test (OGTT). Widely used criteria (e.g. ADA) set diabetes at fasting glucose ≥126 mg/dL, HbA1c ≥6.5% or 2-hour OGTT glucose ≥200 mg/dL, usually confirmed on a second test. Also lipids, creatinine with eGFR and the urine albumin-to-creatinine ratio.
Imaging
Not needed to diagnose. Dilated fundus examination or retinal photography screens for retinopathy; vascular ultrasound when peripheral artery disease is suspected.

Differential diagnosis

  • Type 1 diabetes or latent autoimmune diabetes in adults (LADA)
  • Monogenic diabetes (MODY)
  • Diabetes secondary to pancreatic disease (chronic pancreatitis, pancreatic cancer)
  • Drug-induced hyperglycaemia (glucocorticoids, some antipsychotics)
  • Endocrine causes such as Cushing syndrome or acromegaly

Goal of treatment

Keep glucose in a target range set for each person, avoid hypoglycaemia, and reduce cardiovascular risk (blood pressure, lipids, smoking) to prevent micro- and macrovascular complications.

Treatment

Lifestyle
Structured diet, regular physical activity, weight loss and stopping smoking are the base of treatment at every stage; diabetes self-management education.
Medical
Metformin is the usual first drug. Other classes include SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, sulfonylureas, thiazolidinediones and insulin; SGLT2 inhibitors and GLP-1 agonists are favoured when there is cardiovascular or kidney disease.
Medical
Cardiovascular protection: statins, blood-pressure control (often with ACE inhibitors or ARBs when albuminuria is present) and, in selected people, antiplatelet therapy.
Follow-up
Regular HbA1c, kidney function and urine albumin, lipids, yearly eye and foot examinations, and self-monitoring of glucose in those on insulin.
Surgical
Metabolic (bariatric) surgery is considered in selected people with obesity whose diabetes is not controlled with other measures.

Drugs for this condition

Complications

  • Diabetic retinopathy and macular oedema, a leading cause of preventable blindness; earlier cataract
  • Diabetic kidney disease, a leading cause of chronic kidney failure and dialysis
  • Peripheral neuropathy and autonomic neuropathy (gastroparesis, erectile dysfunction, orthostatic hypotension)
  • Coronary artery disease, stroke and peripheral artery disease
  • Diabetic foot: ulcers, infection and amputation
  • Hyperosmolar hyperglycaemic state and, less often, diabetic ketoacidosis
  • Hypoglycaemia caused by treatment

Prognosis

A chronic, progressive disease that usually needs more treatment over time. Good control of glucose, blood pressure and lipids, plus not smoking, clearly lowers the risk of complications; cardiovascular disease remains the main cause of death.

Prevention

  • Weight loss and regular physical activity in people with prediabetes
  • Screening of adults at risk (overweight with other risk factors, family history, older age)
  • Healthy diet with less sugar-sweetened drinks and ultra-processed food

Test yourself

Think of the answer, then tap the question to see it.

What are the two core defects in type 2 diabetes?

Insulin resistance in muscle, liver and fat, and a progressive failure of pancreatic beta-cell insulin secretion.

Which three standard blood tests are used to diagnose diabetes?

Fasting plasma glucose, HbA1c and the 2-hour oral glucose tolerance test (a random glucose with classic symptoms is also accepted).

What are the three classic microvascular complications of diabetes?

Retinopathy, nephropathy (diabetic kidney disease) and neuropathy.

How does the hyperosmolar hyperglycaemic state differ from diabetic ketoacidosis?

HHS has extreme glucose and osmolality with severe dehydration but little or no ketosis or acidosis; DKA has ketones and metabolic acidosis, usually with lower glucose.

Which drug is the usual first-line agent in type 2 diabetes?

Metformin, alongside lifestyle changes, unless contraindicated.

Add to my cards (5)

Educational information, not medical advice. For any symptom, see a health professional.

Sources: Type 2 Diabetes (StatPearls (NCBI Bookshelf), 2023); Geographical variation in the progression of type 2 diabetes in Peru: The CRONICAS Cohort Study (Diabetes research and clinical practice, 2016) · adapted, CC BY 4.0.

← All conditions

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.

Pancreas highlighted on the Durgical 3D model